Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Updated CDC Immunization Guidelines for 2023-2024 Tripledemic Viruses
CDC immunization recommendations for influenza, COVID-19, and RSV from the updated 2023 schedules are summarized in this Guideline Topline.
The immunization schedules issued by the Centers for Disease Control and Prevention (CDC) in February 2023 contain several important updates, including recommending COVID-19 primary and booster vaccine series for the general population and individuals who are moderately to severely immunocompromised.
In advance of the 2023-2024 respiratory virus season, this Guideline Topline slide show summarizes updates regarding the 3 top respiratory viruses that could work up a tripledemic this year or could be equally menacing each on its own: influenza, COVID-19, and respiratory syncytial virus.
In addition to the CDC highlights, the summaries include recommendations from recent meetings of the CDC's Advisory Committee on Immunization Practices (ACIP) and the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC).All recommendations have been accepted by the CDC as official and either are, or will be posted in The Morbidity and Mortlity Weekly Report (MMWR).
Related Content
